No adequate evidence has been found to prove that discontinuation of TNF antagonists for non-infectious skin lesions can alleviate condition.[46] Pugliese et al[31] initially reported that the combination of biological agents with immunosuppressors could down-regulate the risk of psoriasis.[47]. Here, TNF is linked to psoriasis.